<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Medicine-6) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 21883,
    "choices": [
      {
        "id": 87496,
        "text": "<p><span style=\"font-size:12.0pt;\">Right parietotemporal</span></p>"
      },
      {
        "id": 87497,
        "text": "<p><span style=\"font-size:12.0pt;\">Left parietal</span></p>"
      },
      {
        "id": 87498,
        "text": "<p><span style=\"font-size:12.0pt;\">Right parietal</span></p>"
      },
      {
        "id": 87499,
        "text": "<p><span style=\"font-size:12.0pt;\">Right premotor cortex</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An elderly male patient was brought by his son because he was not using his left arm for day-to-day functioning. He has an unkempt appearance on the left side of his body and has a history of bumping into door frames while walking through them. The evaluation performed is shown below. Where does the lesion in the brain cause this presentation? (FMGE JAN 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/27/screenshot-2024-09-27-181657.png\" alt=\"\" width=\"300\" height=\"209\"></span></p>",
    "unique_key": "Q5604674",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013414,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Right parietal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient\u2019s symptoms suggest left-sided hemineglect, characterized by a lack of awareness of the left side of the body and environment. This is typically caused by a lesion in the non-dominant parietal lobe, which, for most people, is the right parietal lobe. The clock drawing test, where the patient clusters numbers on one side, further supports this diagnosis of hemineglect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Right parietotemporal</strong>: This could affect spatial awareness but is more specific to complex visual and spatial processing issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Left parietal</strong>: Lesions here would affect the right side of the body and typically do not cause hemineglect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Right premotor cortex</strong>: Would affect motor planning but not typically cause hemineglect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Left-sided hemineglect is typically caused by a lesion in the right parietal lobe.</span></p>",
    "correct_choice_id": 87498,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16188,
    "choices": [
      {
        "id": 64712,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic regurgitation</span></p>"
      },
      {
        "id": 64713,
        "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation</span></p>"
      },
      {
        "id": 64714,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic stenosis</span></p>"
      },
      {
        "id": 64715,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral regurgitation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker presented with bilateral pitting pedal edema, and abdominal distension. On examination, he had ascites and auscultation revealed an S3. Which of the following defects can be seen in this patient? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q7966310",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013389,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Tricuspid regurgitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation of bilateral pitting pedal edema, abdominal distension, ascites, and an S3 heart sound is indicative of right heart failure. Tricuspid regurgitation leads to right heart failure because it causes blood to back up into the right atrium and subsequently into the systemic venous circulation, resulting in the observed symptoms. Chronic smoking may contribute to pulmonary hypertension, which can exacerbate right heart failure and tricuspid regurgitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic regurgitation</strong>: Typically causes left heart failure with symptoms like dyspnea and pulmonary congestion, not right heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aortic stenosis</strong>: Leads to left ventricular hypertrophy and heart failure, primarily affecting the left side of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mitral regurgitation</strong>: Primarily affects the left side of the heart and results in pulmonary symptoms and left heart failure rather than right heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation is a common cause of right heart failure, presenting with symptoms such as pedal edema, abdominal distension, and ascites.</span></p>",
    "correct_choice_id": 64713,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11325,
    "choices": [
      {
        "id": 45266,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypernatremia</span></span></p>"
      },
      {
        "id": 45267,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyponatremia</span></span></p>"
      },
      {
        "id": 45268,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia</span></span></p>"
      },
      {
        "id": 45269,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents with a seizure. On evaluation, urine osmolality is 1000 mOsm/Kg and serum osmolality is 270 mOsm/Kg. Which electrolyte abnormality can be expected in this patient?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
    "unique_key": "Q4110468",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013384,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Hyponatremia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s laboratory findings show high urine osmolality and low serum osmolality, which are indicative of a condition where the kidneys are concentrating urine despite low blood osmolality. This is characteristic of the syndrome of inappropriate antidiuretic hormone (SIADH) secretion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In SIADH, excessive release of antidiuretic hormone (ADH) leads to water retention, dilutional hyponatremia (low serum sodium), and the production of concentrated urine (high urine osmolality). The body retains water, which dilutes the blood sodium levels but the kidneys continue to excrete sodium, resulting in a low serum osmolality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Differential diagnosis - Cerebral Salt Wasting Syndrome (CSWS)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Fluid Status</span></strong><span style=\"font-size:12.0pt\">: Patients are hypovolemic, meaning there is a reduced volume of circulating fluid in the body.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Characteristics</span></strong><span style=\"font-size:12.0pt\">: It involves the loss of sodium from the body, which exceeds the loss of water, leading to hyponatremia and decreased blood volume. This condition is often associated with neurological disorders such as injuries or diseases affecting the brain.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hypernatremia:</span></strong><span style=\"font-size:12.0pt\"> Hypernatremia refers to high sodium levels in the blood, which would typically be associated with high serum osmolality. This does not fit the patient&#39;s laboratory findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hyperkalemia:</span></strong><span style=\"font-size:12.0pt\"> Hyperkalemia is an elevated level of potassium in the blood and does not correlate with the osmolality findings presented.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypokalemia:</span></strong><span style=\"font-size:12.0pt\"> Hypokalemia is a low potassium level in the blood and, while it can be associated with various conditions, it is not directly indicated by the osmolality findings described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients presenting with low serum osmolality and high urine osmolality, SIADH is a likely diagnosis, and the primary electrolyte abnormality to expect is hyponatremia.</span></span></p>",
    "correct_choice_id": 45267,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16444,
    "choices": [
      {
        "id": 65736,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phentolamine</span></span></p>"
      },
      {
        "id": 65737,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicardipine</span></span></p>"
      },
      {
        "id": 65738,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannitol</span></span></p>"
      },
      {
        "id": 65739,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prazosin</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A known hypertensive patient is brought to the ER with palpitations and breathlessness. On examination, his BP was 220/140 with signs of encephalopathy. Which of the following is used as a 1st line drug? (FMGE JUNE 2022)</span></span></span></p>",
    "unique_key": "Q3118698",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013388,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Nicardipine</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In hypertensive emergencies, particularly with signs of encephalopathy, IV Nicardipine, a calcium channel blocker, is often used due to its effectiveness in quickly lowering blood pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Alternative T/t &ndash; IV </span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Labetalol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Phentolamine:</span></strong><span style=\"font-size:12.0pt\"> Used for pheochromocytoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mannitol:</span></strong><span style=\"font-size:12.0pt\"> Used for cerebral edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Prazosin:</span></strong><span style=\"font-size:12.0pt\"> An alpha-blocker used for hypertension but not first-line in emergencies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nicardipine is the first-line drug for hypertensive emergencies with encephalopathy.</span></span></span></p>",
    "correct_choice_id": 65737,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47550,
    "choices": [
      {
        "id": 189811,
        "text": "<p><span style=\"font-size:12.0pt;\">c-ANCA</span></p>"
      },
      {
        "id": 189812,
        "text": "<p><span style=\"font-size:12.0pt;\">ANA</span></p>"
      },
      {
        "id": 189813,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-histone antibodies</span></p>"
      },
      {
        "id": 189814,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-Jo 1 antibodies</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old male patient presented with complaints of paranasal sinus pain and bloody nasal discharge for the past few days. He also has a previous history of hemoptysis and hematuria. Imaging revealed multiple, bilateral, nodular cavitary infiltrates. Which of the following antibodies would be positive in this patient?</span></p>",
    "unique_key": "Q1080404",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013415,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) c-ANCA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation suggests <strong>granulomatosis with polyangiitis</strong> (GPA), formerly known as <strong>Wegener's granulomatosis</strong>. GPA triad typically involves:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>ENT involvement:&nbsp;</strong>Sinus pain and bloody nasal discharge (sinusitis).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pulmonary involvement:&nbsp;</strong>Hemoptysis and cavitating nodules on imaging.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Renal involvement:&nbsp;</strong>Hematuria and rapidly progressive glomerulonephritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The characteristic antibody associated with GPA is <strong>c-ANCA</strong> (cytoplasmic anti-neutrophil cytoplasmic antibodies), which targets proteinase 3.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ANA (Antinuclear Antibodies):&nbsp;</strong>Typically associated with systemic lupus erythematosus and other autoimmune diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anti-histone antibodies:&nbsp;</strong>Associated with drug-induced lupus erythematosus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti-Jo 1 antibodies:&nbsp;</strong>Associated with polymyositis and dermatomyositis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Granulomatosis with polyangiitis (GPA) is associated with c-ANCA (anti-proteinase 3 antibodies), presenting with ENT, pulmonary, and renal involvement.</span></p>",
    "correct_choice_id": 189811,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47548,
    "choices": [
      {
        "id": 189803,
        "text": "<p><span style=\"font-size:12.0pt;\">Smallpox</span></p>"
      },
      {
        "id": 189804,
        "text": "<p><span style=\"font-size:12.0pt;\">Chickenpox</span></p>"
      },
      {
        "id": 189805,
        "text": "<p><span style=\"font-size:12.0pt;\">Monkeypox</span></p>"
      },
      {
        "id": 189806,
        "text": "<p><span style=\"font-size:12.0pt;\">Shingles</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 3-year-old child presents with the following lesions that started 2 days after he developed a fever. On examination, there are generalized vesicular eruptions over the trunk. What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-160525.png\" alt=\"\" width=\"300\" height=\"195\"></span></p>",
    "unique_key": "Q8455571",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013390,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chickenpox</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The description and image provided indicate a diagnosis of <strong>chickenpox</strong> (varicella). Key features include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Generalized vesicular eruptions&nbsp;</strong>over the trunk.</span></li><li><span style=\"font-size:12.0pt;\">The lesions appear as \"dew drops on a rose petal,\" which is characteristic of chickenpox.</span></li><li><span style=\"font-size:12.0pt;\">Chickenpox lesions are typically in various stages of development (macules, papules, vesicles, and crusts) at the same time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Smallpox:&nbsp;</strong>Presents with a more uniform appearance of lesions and typically starts on the face and extremities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Monkeypox:&nbsp;</strong>Presents with fever, lymphadenopathy, and a rash that is similar to smallpox but usually more severe.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Shingles:&nbsp;</strong>Generally presents in a dermatomal distribution and occurs in older individuals or those with a history of varicella.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chickenpox is characterized by generalized vesicular eruptions that look like \"dew drops on a rose petal\" and appear in various stages simultaneously.</span></p>",
    "correct_choice_id": 189804,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84283,
    "choices": [
      {
        "id": 335708,
        "text": "<p><span style=\"font-size:12.0pt;\">Post-streptococcal Glomerulonephritis (PSGN)</span></p>"
      },
      {
        "id": 335709,
        "text": "<p><span style=\"font-size:12.0pt;\">Mixed Cryoglobulinemia</span></p>"
      },
      {
        "id": 335710,
        "text": "<p><span style=\"font-size:12.0pt;\">Membranoproliferative Glomerulonephritis (MPGN)</span></p>"
      },
      {
        "id": 335711,
        "text": "<p><span style=\"font-size:12.0pt;\">Focal Segmental Glomerular Sclerosis (FSGS)</span></p>"
      }
    ],
    "text": "<p>A 30-year-old male presents with generalized edema and hypertension. Urine examination reveals subnephrotic proteinuria (&lt;2g/day) and microscopic hematuria. Serum complement levels are low, and the patient tests positive for anti-hepatitis C antibodies. What is the most likely diagnosis? (NEET PG 2016)</p>",
    "unique_key": "Q6283621",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013506,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. B) Mixed Cryoglobulinemia</strong></p><p>&nbsp;</p><p>This patient presents with the classic triad of mixed cryoglobulinemia: hepatitis C infection, low complement levels, and glomerular involvement manifesting as subnephrotic proteinuria and hematuria. Mixed cryoglobulinemia is strongly associated with hepatitis C virus (HCV) infection. The condition involves circulating cryoglobulins (immune complexes that precipitate at cold temperatures) that deposit in glomerular capillaries, causing a membranoproliferative pattern of injury with hypocomplementemia.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Post-streptococcal Glomerulonephritis (PSGN)</strong>: While PSGN presents with low complement levels (especially C3), hematuria, and proteinuria, it follows streptococcal pharyngitis or impetigo, not hepatitis C infection. PSGN typically has ASO titer elevation and/or other evidence of streptococcal infection, which isn't mentioned here.</p><p>&nbsp;</p><p><strong>Option C. Membranoproliferative Glomerulonephritis (MPGN)</strong>: This is a histologic pattern that can occur in hepatitis C infection, but cryoglobulinemic glomerulonephritis is the more specific diagnosis with hepatitis C. In fact, cryoglobulinemic glomerulonephritis often presents with an MPGN pattern on biopsy, making this a less specific diagnosis.</p><p>&nbsp;</p><p><strong>Option D. Focal Segmental Glomerular Sclerosis (FSGS)</strong>: FSGS typically presents with nephrotic-range proteinuria (&gt;3.5g/day), and complement levels are usually normal. While secondary FSGS can occur with viral infections, hepatitis C is not a common cause. The subnephrotic proteinuria and hypocomplementemia make this diagnosis unlikely.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Mixed cryoglobulinemia should be strongly considered in any patient with hepatitis C infection who presents with renal manifestations, particularly when accompanied by hypocomplementemia and subnephrotic proteinuria.</p>",
    "correct_choice_id": 335709,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "OlderNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11584,
    "choices": [
      {
        "id": 46302,
        "text": "<p><span style=\"font-size:12.0pt;\">Diazepam</span></p>"
      },
      {
        "id": 46303,
        "text": "<p><span style=\"font-size:12.0pt;\">Alprazolam</span></p>"
      },
      {
        "id": 46304,
        "text": "<p><span style=\"font-size:12.0pt;\">Clonazepam</span></p>"
      },
      {
        "id": 46305,
        "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old chronic alcoholic presented with withdrawal symptoms. His liver function tests showed:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AST 140 IU/L,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALT 110 IU/L, and</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GGT 500 IU/L.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following benzodiazepines can be safely administered to this patient? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q8331787",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013400,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Lorazepam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's liver function tests indicate elevated liver enzymes (AST, ALT, and GGT), suggesting potential alcoholic hepatitis or liver impairment. In such cases, choosing the appropriate benzodiazepine is crucial due to the liver's role in drug metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lorazepam is a preferred benzodiazepine in patients with liver impairment for the following reasons:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Short-acting</strong>: Lorazepam is a short-acting benzodiazepine, which means it has a shorter half-life and less risk of accumulation in the body compared to long-acting benzodiazepines.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Minimal liver metabolism</strong>: Lorazepam undergoes minimal hepatic metabolism, which makes it safer for patients with impaired liver function. This reduces the risk of adverse effects and toxicity.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Diazepam:</strong> Diazepam is a long-acting benzodiazepine. It undergoes extensive hepatic metabolism, leading to active metabolites that can accumulate, especially in patients with liver dysfunction. This increases the risk of prolonged sedation and toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Alprazolam:</strong> Alprazolam, although shorter-acting than diazepam, still undergoes significant liver metabolism. It is not as safe as lorazepam in patients with compromised liver function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clonazepam</strong>: Clonazepam is also a long-acting benzodiazepine with extensive hepatic metabolism. Like diazepam, its use in patients with liver impairment can lead to accumulation and increased risk of side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with liver impairment, such as those with alcoholic hepatitis, lorazepam is the preferred benzodiazepine due to its short-acting nature and minimal hepatic metabolism.</span></p>",
    "correct_choice_id": 46305,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74889,
    "choices": [
      {
        "id": 298453,
        "text": "<p><span style=\"font-size:16px;\">Plasmapheresis is not effective in refractory GBS</span></p>"
      },
      {
        "id": 298454,
        "text": "<p><span style=\"font-size:16px;\">IV immunoglobulins are the first line of treatment</span></p>"
      },
      {
        "id": 298455,
        "text": "<p><span style=\"font-size:16px;\">Areflexia in the weaker arm is included in diagnostic criteria</span></p>"
      },
      {
        "id": 298456,
        "text": "<p><span style=\"font-size:16px;\">Albumino-cytological dissociation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Regarding Guillain-Barr\u00e9 syndrome (GBS) in children, which of the following statements is false? (INICET NOV 2024)</span></p>",
    "unique_key": "Q6128570",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013420,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Plasmapheresis is not effective in refractory GBS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Plasmapheresis (plasma exchange, PEX) is a well-established and effective treatment in GBS, including in refractory or severe cases. It is considered equivalent in efficacy to IVIG and may be used in patients not responding to IVIG (controversial, and sequential administration of PEX after IVIG is not recommended, but some clinicians try on a case-by-case basis), or if IVIG is contraindicated or unavailable.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. IV immunoglobulins are the first line of treatment:</strong> Correct. IVIG can be used as first-line treatment, having equal efficacy to plasma exchange in GBS management.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Areflexia in the weaker arm is included in diagnostic criteria:</strong> Correct. Areflexia in the weaker arm is a mandatory diagnostic criterion according to Brighton criteria. GBS is a demyelinating disease affecting large fibers that form the basis of reflex arcs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Albumino-cytological dissociation:</strong> Correct. It is a classic feature of GBS, with high protein in CSF but normal cell count (&lt;10 cells). Any cell count &gt;50 essentially rules out GBS.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Plasmapheresis and IVIG are effective treatment options for GBS, including refractory cases, with neither being superior to the other. Never use immunosuppression or steroids in acute GBS.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vQdge7y.png\" width=\"1155\" height=\"629\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Level of diagnostic certainty in Brighton criteria for GBS</strong></span></p>",
    "correct_choice_id": 298453,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "CriteriaBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52369,
    "choices": [
      {
        "id": 208969,
        "text": "<p><span style=\"font-size:12.0pt;\">Deferoxamine</span></p>"
      },
      {
        "id": 208970,
        "text": "<p><span style=\"font-size:12.0pt;\">Activated charcoal</span></p>"
      },
      {
        "id": 208971,
        "text": "<p><span style=\"font-size:12.0pt;\">Dimercaprol</span></p>"
      },
      {
        "id": 208972,
        "text": "<p><span style=\"font-size:12.0pt;\">Penicillamine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A child presents to the emergency department with a history of ingestion of 10-20 ferrous sulfate tablets. Arterial blood gas revealed acidosis. Which of the following can be used in the management of this condition? (Neet pg 2022)</span></p>",
    "unique_key": "Q7613841",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013410,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Deferoxamine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron overdose, particularly with ferrous sulfate tablets, can lead to severe toxicity. Ingesting more than 60 mg/kg of elemental iron is considered potentially lethal. Acute iron poisoning presents with gastrointestinal symptoms initially and can progress to metabolic acidosis, shock, and multi-organ failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of acidosis on arterial blood gas analysis is an important indicator of severe iron toxicity and an indication for the administration of an antidote. The appropriate antidote for acute iron intoxication is&nbsp;<strong>deferoxamine</strong>. Deferoxamine chelates free iron, forming a water-soluble complex that is excreted in the urine, thereby reducing iron's toxic effects on the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Activated charcoal:&nbsp;</strong>Activated charcoal is not effective in cases of iron poisoning. It does not adsorb metals like iron and can be harmful in certain situations like heavy metal poisoning, alcohols, petroleum products, and caustic substances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Dimercaprol:&nbsp;</strong>Dimercaprol is used for chelation therapy in heavy metal poisoning (e.g., arsenic, mercury, gold) but is not effective for iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Penicillamine:&nbsp;</strong>Penicillamine is another chelating agent, typically used for conditions such as Wilson's disease (copper overload) and rheumatoid arthritis. It is not effective in treating iron toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of acute iron intoxication with signs of toxicity such as acidosis, the antidote of choice is deferoxamine. Activated charcoal is not effective in iron poisoning and should not be used.</span></p>",
    "correct_choice_id": 208969,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11227,
    "choices": [
      {
        "id": 44874,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
      },
      {
        "id": 44875,
        "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
      },
      {
        "id": 44876,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism</span></p>"
      },
      {
        "id": 44877,
        "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions is associated with AV block?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
    "unique_key": "Q1680224",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013508,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Hypothyroidism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypothyroidism can lead to various cardiac manifestations, including bradycardia and atrioventricular (AV) block. This is due to the metabolic effects of low thyroid hormone levels, which slow down the heart rate and can increase the risk of heart block. This type of AV block is generally reversible and often improves with appropriate thyroid hormone replacement therapy, such as levothyroxine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cushing's syndrome:&nbsp;</strong>Typically associated with other cardiovascular issues such as hypertension due to excessive cortisol levels, but not commonly with AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hyperthyroidism:&nbsp;</strong>Usually results in symptoms opposite to those of hypothyroidism, like tachycardia or atrial fibrillation, rather than AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pheochromocytoma:&nbsp;</strong>This condition, characterized by excess production of catecholamines, typically presents with episodic hypertension and tachycardia, not AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypothyroidism causes reversible AV Block that improves with LT4 supplementation.</span></p>",
    "correct_choice_id": 44874,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16299,
    "choices": [
      {
        "id": 65156,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urinary Metanephrines and VMA</span></span></span></p>"
      },
      {
        "id": 65157,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Albumin</span></span></span></p>"
      },
      {
        "id": 65158,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5-HIAA</span></span></span></p>"
      },
      {
        "id": 65159,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is used as a screening test for pheochromocytoma?</span></span></p>",
    "unique_key": "Q6832984",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013387,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Urinary Metanephrines and VMA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pheochromocytoma is a catecholamine-secreting tumor that arises from the adrenal medulla. The best screening test for pheochromocytoma is the measurement of urinary metanephrines and vanillylmandelic acid (VMA), which are metabolites of catecholamines. Elevated levels of these metabolites in the urine are indicative of pheochromocytoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">24-hour urinary fractionated catecholamines, metanephrines, normetanephrines, and VMA assays.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Albumin</span></strong><span style=\"font-size:12.0pt\">: Not relevant for diagnosing pheochromocytoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 5-HIAA</span></strong><span style=\"font-size:12.0pt\">: This test is used for diagnosing carcinoid syndrome, not pheochromocytoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Glucose</span></strong><span style=\"font-size:12.0pt\">: Blood glucose levels are not related to the diagnosis of pheochromocytoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urinary metanephrines and VMA are the screening tests of choice for pheochromocytoma.</span></span></span></p>",
    "correct_choice_id": 65156,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11980,
    "choices": [
      {
        "id": 47885,
        "text": "<p><span style=\"font-size:12.0pt;\">Carboxyhemoglobinemia</span></p>"
      },
      {
        "id": 47886,
        "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
      },
      {
        "id": 47887,
        "text": "<p><span style=\"font-size:12.0pt;\">Methemoglobinemia</span></p>"
      },
      {
        "id": 47888,
        "text": "<p><span style=\"font-size:12.0pt;\">Sulfhemoglobinemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to the AIIMS emergency department with severe fatigue and prostration. She is a known case of chronic stable angina. While collecting a blood sample, you notice the blood has a brownish hue. What is the underlying diagnosis? (INICET NOV 2022)</span></p>",
    "unique_key": "Q5215309",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013424,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;C) Methemoglobinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presenting with a brownish hue in the blood, coupled with a history of chronic stable angina, points towards methemoglobinemia. Patients with chronic stable angina are often on nitrate therapy, which is a known risk factor for developing methemoglobinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methemoglobinemia occurs when the iron in hemoglobin is oxidized from the ferrous (Fe\u00b2\u207a) state to the ferric (Fe\u00b3\u207a) state, which is unable to bind oxygen effectively. This results in reduced oxygen delivery to tissues, leading to symptoms such as fatigue and cyanosis. The brownish hue of the blood, often described as chocolate-colored, is characteristic of methemoglobinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Carboxyhemoglobinemia:</strong> Carboxyhemoglobinemia is caused by carbon monoxide poisoning, typically associated with exposure to fire or automobile exhaust. The blood in this condition has a cherry red color, not brownish.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sideroblastic anemia:</strong> Sideroblastic anemia is a form of anemia where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. It does not cause a brownish hue in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sulfhemoglobinemia:</strong> Sulfhemoglobinemia results from the incorporation of sulfur into hemoglobin, leading to a greenish or bluish color of the blood, rather than brownish.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A brownish hue in the blood, especially in a patient on nitrate therapy, is indicative of methemoglobinemia, a condition where hemoglobin is oxidized, impairing its ability to carry oxygen effectively.</span></p>",
    "correct_choice_id": 47887,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 45582,
    "choices": [
      {
        "id": 181967,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic Regurgitation</span></p>"
      },
      {
        "id": 181968,
        "text": "<p><span style=\"font-size:14.0pt;\">Tricuspid Regurgitation</span></p>"
      },
      {
        "id": 181969,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral Stenosis</span></p>"
      },
      {
        "id": 181970,
        "text": "<p><span style=\"font-size:12.0pt;\">Pericardial Effusion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Duroziez\u2019s sign is seen in? (NEET PG 2017)</span></p>",
    "unique_key": "Q1998355",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013507,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. A) Aortic Regurgitation</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Duroziez's sign is a clinical finding specifically associated with aortic regurgitation. This sign consists of a to-and-fro murmur heard over the femoral artery when it is lightly compressed with a stethoscope. This peripheral manifestation occurs because of the wide pulse pressure and rapid diastolic runoff characteristic of significant aortic regurgitation. Duroziez's sign appears alongside other peripheral signs of aortic regurgitation in the clinical examination.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Tricuspid Regurgitation</strong>: Tricuspid regurgitation is characterized by prominent c-v waves in the jugular venous pulse, a systolic murmur along the left sternal border that increases with inspiration (Carvallo's sign), and signs of right heart failure including hepatomegaly, ascites, and edema. Duroziez's sign, which involves the femoral artery, is not associated with tricuspid regurgitation.</p><p>&nbsp;</p><p><strong>Option C. Mitral Stenosis</strong>: Mitral stenosis presents with a diastolic rumbling murmur at the apex, an opening snap, pulmonary congestion, and potential atrial fibrillation. The key signs include prominent waves in the jugular venous pulse if in sinus rhythm and hemoptysis in some cases. Duroziez's sign is not characteristic of mitral stenosis.</p><p>&nbsp;</p><p><strong>Option D. Pericardial Effusion</strong>: Pericardial effusion is associated with muffled heart sounds, increased cardiac dullness to percussion, electrical alternans on ECG in large effusions, and pulsus paradoxus. Duroziez's sign involves arterial auscultation and is not related to pericardial effusion.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Duroziez's sign (to-and-fro murmur heard over the compressed femoral artery) is a specific peripheral finding in aortic regurgitation, occurring alongside other peripheral signs including Corrigan's water-hammer pulse, capillary pulsations (Quincke's sign), and Traube's sign (pistol-shot sound over femoral arteries).</p>",
    "correct_choice_id": 181967,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11537,
    "choices": [
      {
        "id": 46114,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastatic breast cancer</span></p>"
      },
      {
        "id": 46115,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      },
      {
        "id": 46116,
        "text": "<p><span style=\"font-size:12.0pt;\">Primary hyperparathyroidism</span></p>"
      },
      {
        "id": 46117,
        "text": "<p><span style=\"font-size:12.0pt;\">Milk Alkali Syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman presented with symptoms of confusion, thirst, and abdominal pain. On examination, she had pallor and thoracic spine tenderness. X-ray spine showed osteolytic lesions. Her lab investigations showed the following findings: Hb - 6.9g/dL, WBC 4000/cm3 with normal differential count, Serum calcium 13mg/dL, Creatinine 2.3mg/dL, Total protein 9g/dL, Albumin 2.4g/dL. What is the most likely diagnosis? (INICET MAY 2021)</span></p>",
    "unique_key": "Q8043353",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013503,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Multiple myeloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient's symptoms, combined with lab findings of anemia, hypercalcemia, elevated total protein, and low albumin, along with osteolytic lesions, are indicative of multiple myeloma. The <strong>CRAB criteria</strong> (hyperCalcemia, Renal failure, Anemia, and Bone lesions) support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Metastatic breast cancer</strong> can present similarly but usually has a different primary site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Primary hyperparathyroidism</strong> causes hypercalcemia but not the full CRAB criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Milk Alkali Syndrome</strong> causes hypercalcemia and renal impairment but not the protein abnormalities or osteolytic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Multiple myeloma is characterized by anemia, hypercalcemia, renal failure, and bone lesions.</span></p>",
    "correct_choice_id": 46115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11241,
    "choices": [
      {
        "id": 44930,
        "text": "<p><span style=\"font-size:12.0pt;\">Intrinsic asthma</span></p>"
      },
      {
        "id": 44931,
        "text": "<p><span style=\"font-size:12.0pt;\">Brittle asthma</span></p>"
      },
      {
        "id": 44932,
        "text": "<p><span style=\"font-size:12.0pt;\">Extrinsic asthma</span></p>"
      },
      {
        "id": 44933,
        "text": "<p><span style=\"font-size:12.0pt;\">Exercise-induced asthma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Nasal polyps are commonly associated with: (NEET PG 2019)</span></p>",
    "unique_key": "Q4007502",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013407,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Intrinsic asthma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intrinsic asthma, also known as non-allergic asthma, is often associated with nasal polyps. This type of asthma does not have an allergic or atopic component and tends to develop in adulthood. Intrinsic asthma is characterized by a non-IgE mediated pathway involving eosinophils and neutrophils, often triggered by non-allergic factors such as viral infections, stress, or exercise. Nasal polyps in this context are linked to chronic inflammation of the sinuses and nasal passages, common in non-allergic forms of asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Brittle asthma:&nbsp;</strong>This is a term used to describe a severe form of asthma where patients experience frequent, severe exacerbations. While serious, it does not specifically correlate with the presence of nasal polyps more than other types of asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Extrinsic asthma:&nbsp;</strong>Known as allergic asthma, it is mediated by IgE and typically involves allergen triggers like pollen, dust mites, and molds. Nasal polyps are less commonly associated with this subtype compared to intrinsic asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Exercise-induced asthma:&nbsp;</strong>This condition, characterized by bronchoconstriction triggered by physical activity, is not typically associated with nasal polyps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-110232.jpg\" alt=\"\" width=\"1000\" height=\"443\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Pulmonology/Asthma/Chap 287</strong></span></p>",
    "correct_choice_id": 44930,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16445,
    "choices": [
      {
        "id": 65740,
        "text": "<p><span style=\"font-size:12.0pt;\">Desaturation</span></p>"
      },
      {
        "id": 65741,
        "text": "<p><span style=\"font-size:12.0pt;\">Altered mental status</span></p>"
      },
      {
        "id": 65742,
        "text": "<p><span style=\"font-size:12.0pt;\">Increase in blood pressure</span></p>"
      },
      {
        "id": 65743,
        "text": "<p><span style=\"font-size:12.0pt;\">Retinal hemorrhage</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A young man presents with a sudden onset of severe headache, dizziness, breathlessness, and blurring of vision while trekking on a mountain at an altitude of 5000 meters. He is unable to climb any further. Which of the following indicates the development of high-altitude cerebral edema? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q4976934",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013413,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Altered mental status</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High-altitude cerebral edema (HACE) is characterized by symptoms such as altered mental status, ataxia, and possibly coma. These symptoms indicate severe altitude sickness requiring immediate descent and possibly medication like dexamethasone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Detailed protocol for managing severe high altitude-related illnesses, specifically High Altitude Pulmonary Edema (HAPE) and High Altitude Cerebral Edema (HACE):</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Immediate Descent</strong>: The primary and most effective treatment for HAPE and HACE is to descend to a lower altitude as soon as possible. This is critical because it directly addresses the cause of the symptoms by reducing altitude exposure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Portable Hyperbaric Bags</strong>: If immediate descent is not feasible due to terrain or other factors, portable hyperbaric bags are the next best alternative. These simulate a lower altitude environment and can stabilize the patient while descent is arranged.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Medications</strong>:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Dexamethasone</strong>: Effective for both HAPE and HACE, this medication can reduce inflammation and cerebral swelling.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Nifedipine</strong>: Recommended specifically for HAPE, as it helps reduce pulmonary artery pressure but is not effective for HACE.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Oxygen and CPAP (Continuous Positive Airway Pressure)</strong>: These are additional treatments for HAPE to improve oxygenation, though the discussion of their use is noted as beyond the scope of the current conversation.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Desaturation:</strong> More indicative of high-altitude pulmonary edema (HAPE).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increase in blood pressure:</strong> Not specific to HACE.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Retinal hemorrhage:</strong> Can occur at high altitudes but is not a primary indicator of HACE.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Altered mental status is a key indicator of high-altitude cerebral edema.</span></p>",
    "correct_choice_id": 65741,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47616,
    "choices": [
      {
        "id": 190075,
        "text": "<p><span style=\"font-size:12.0pt;\">CT angiography</span></p>"
      },
      {
        "id": 190076,
        "text": "<p><span style=\"font-size:12.0pt;\">Duplex USG</span></p>"
      },
      {
        "id": 190077,
        "text": "<p><span style=\"font-size:12.0pt;\">X-ray</span></p>"
      },
      {
        "id": 190078,
        "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A post-operative patient who is immobilized develops sudden onset severe calf pain. What is the next investigation to be done? (</span>FMGE Jan 2024)</p>",
    "unique_key": "Q2942445",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013416,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Duplex USG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is duplex ultrasound (USG). The clinical picture suggests deep vein thrombosis (DVT), which is a common complication in immobilized, post-operative patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Duplex ultrasound is the investigation of choice for diagnosing DVT as it combines traditional ultrasound and Doppler ultrasound to visualize blood flow and identify any thrombus in the veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CT angiography:&nbsp;</strong>This is primarily used for pulmonary embolism, not for initial evaluation of suspected DVT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. X-ray:&nbsp;</strong>This is not useful for diagnosing DVT, as it does not provide information about the veins or blood flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. MRI:&nbsp;</strong>While MRI can visualize DVT, it is not the first-line investigation due to higher cost, longer procedure time, and less availability compared to duplex ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For post-operative, immobilized patients with sudden onset severe calf pain, suggesting DVT, the next investigation should be a duplex ultrasound, which effectively visualizes the veins and assesses blood flow to confirm the diagnosis. \u200b</span></p>",
    "correct_choice_id": 190076,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47615,
    "choices": [
      {
        "id": 190071,
        "text": "<p><span style=\"font-size:12.0pt;\">OPD management</span></p>"
      },
      {
        "id": 190072,
        "text": "<p><span style=\"font-size:12.0pt;\">IPD management</span></p>"
      },
      {
        "id": 190073,
        "text": "<p><span style=\"font-size:12.0pt;\">ICU management (oral drugs)</span></p>"
      },
      {
        "id": 190074,
        "text": "<p><span style=\"font-size:12.0pt;\">ICU management (IV drugs)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old patient has fever with severe shortness of breath and red currant jelly sputum. On examination, he has altered sensorium with a respiratory rate of 35 breaths/min. Lab investigations show serum creatinine of 1.9 mg/dL. CXR is done and shows multi-lobar infiltrates. What is correct regarding the management? (</span>FMGE Jan 2024)</p>",
    "unique_key": "Q7328915",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013391,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) ICU management (IV drugs)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with severe symptoms of community-acquired pneumonia, including fever, severe shortness of breath, red currant jelly sputum, altered sensorium, a high respiratory rate, and multi-lobar infiltrates on the chest X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CURB-65 score and IDSA/ATS guidelines for severe community-acquired pneumonia suggest that patients with severe symptoms, especially those meeting major criteria or multiple minor criteria, require intensive care unit (ICU) management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CURB-65 Criteria (score 0-5)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Confusion</span></li><li><span style=\"font-size:12.0pt;\">Uremia (BUN &gt; 19 mg/dL or Urea &gt;40 mg/dL)</span></li><li><span style=\"font-size:12.0pt;\">Respiratory rate \u2265 30/min</span></li><li><span style=\"font-size:12.0pt;\">Blood pressure (systolic <u>&lt;</u> 90 mmHg or diastolic \u2264 60 mmHg)</span></li><li><span style=\"font-size:12.0pt;\">Age \u2265 65 years</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient scores high on these criteria due to confusion, high respiratory rate, and multi-lobar infiltrates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IDSA/ATS Criteria for Severe CAP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Minor Criteria</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Respiratory rate \u2265 30 breaths/min</span></li><li><span style=\"font-size:12.0pt;\">PaO2/FiO2 ratio \u2264 250</span></li><li><span style=\"font-size:12.0pt;\">Multi-lobar infiltrates</span></li><li><span style=\"font-size:12.0pt;\">Confusion/disorientation</span></li><li><span style=\"font-size:12.0pt;\">Uremia (BUN level \u2265 20 mg/dL)</span></li><li><span style=\"font-size:12.0pt;\">Leukopenia (WBC count &lt; 4000 cells/mm3)</span></li><li><span style=\"font-size:12.0pt;\">Thrombocytopenia (platelet count &lt; 100,000 cells/mm3)</span></li><li><span style=\"font-size:12.0pt;\">Hypothermia (core temperature &lt; 36\u00b0C)</span></li><li><span style=\"font-size:12.0pt;\">Hypotension requiring aggressive fluid resuscitation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Major Criteria</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Septic shock requiring vasopressors</span></li><li><span style=\"font-size:12.0pt;\">Respiratory failure requiring mechanical ventilation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient meets several minor criteria, indicating severe CAP requiring ICU admission and intravenous antibiotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. OPD management:&nbsp;</strong>Not appropriate for severe symptoms and high CURB-65 score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IPD management:&nbsp;</strong>While necessary, ICU care is more appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ICU management (oral drugs):&nbsp;</strong>IV drugs are required for severe cases in the ICU.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with severe community-acquired pneumonia, especially those with altered sensorium, high respiratory rate, and multi-lobar infiltrates, should be managed in the ICU with intravenous antibiotics.</span></p>",
    "correct_choice_id": 190074,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11762,
    "choices": [
      {
        "id": 47014,
        "text": "<p><span style=\"font-size:12.0pt;\">SLE</span></p>"
      },
      {
        "id": 47015,
        "text": "<p><span style=\"font-size:12.0pt;\">Ulcerative colitis</span></p>"
      },
      {
        "id": 47016,
        "text": "<p><span style=\"font-size:12.0pt;\">Behcet's disease</span></p>"
      },
      {
        "id": 47017,
        "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Iritis is seen in all except: (INICET NOV 2020</span></p>",
    "unique_key": "Q2172577",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013402,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Rheumatoid Arthritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iritis, or inflammation of the iris, is not commonly associated with Rheumatoid Arthritis (RA). Instead, RA is more commonly linked to other ocular conditions such as episcleritis and scleritis, which affect different parts of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. SLE</strong>: Systemic Lupus Erythematosus can involve various parts of the eye, including the development of uveitis, which includes iritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ulcerative Colitis</strong>: This inflammatory bowel disease is known to have extraintestinal manifestations including uveitis, which encompasses iritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Behcet's Disease:</strong>&nbsp;This is a multisystem inflammatory disorder that commonly affects the eyes, including the iris, making iritis a typical manifestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis is typically associated with <strong>scleral and episcleral inflammation</strong> rather than iritis, distinguishing it from other autoimmune conditions like SLE, Ulcerative Colitis, and Behcet's Disease that can present with iritis as a part of their systemic manifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Rheumatoid arthritis</strong></span></p>",
    "correct_choice_id": 47017,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11226,
    "choices": [
      {
        "id": 44870,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient who died during transportation to the hospital</span></p>"
      },
      {
        "id": 44871,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient who died after failed resuscitation after reaching the hospital</span></p>"
      },
      {
        "id": 44872,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient who was brought dead to the hospital</span></p>"
      },
      {
        "id": 44873,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient who is awaiting death in the hospital</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following patients comes under the category III non-heart-beating donor?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
    "unique_key": "Q5189011",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013406,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. A patient who is awaiting death in the hospital</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-heart beating donor = Donation after circulatory death (DCD)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Category III non-heart-beating donors, also known as Donation after Circulatory Death (DCD), specifically refers to patients who are anticipated to have an imminent cardiac arrest, usually while in the hospital. These patients are often on ventilator support, and the decision to withdraw life-sustaining treatment is made due to irreversible medical conditions. The donation process is planned, and organs are procured once circulatory death is confirmed following the withdrawal of support.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. A patient who died during transportation to the hospital:&nbsp;</strong>This would typically fall under Category I (Dead on Arrival) if they arrive with irreversible cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. A patient who died after failed resuscitation after reaching the hospital:&nbsp;</strong>This falls under Category II, which involves unsuccessful resuscitation efforts in the emergency room.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. A patient who was brought dead to the hospital:&nbsp;</strong>Similar to option A, this is classified under Category I.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Modified Maastricht Classification categorizes DCD:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164155.jpg\" alt=\"\" width=\"1000\" height=\"311\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Renal transplantation/Table 313-1.</strong></span></p>",
    "correct_choice_id": 44873,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11533,
    "choices": [
      {
        "id": 46098,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixed distal airway obstruction</span></p>"
      },
      {
        "id": 46099,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixed central airway obstruction</span></p>"
      },
      {
        "id": 46100,
        "text": "<p><span style=\"font-size:12.0pt;\">Variable intrathoracic obstruction</span></p>"
      },
      {
        "id": 46101,
        "text": "<p><span style=\"font-size:12.0pt;\">Variable extra thoracic obstruction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the pathology from the given flow-volume loop: (INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-154508.png\" alt=\"\" width=\"300\" height=\"259\"></span></p>",
    "unique_key": "Q7690013",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013401,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Fixed central airway obstruction</strong></span></p><p><br><span style=\"font-size:12pt;\">The flow-volume loop shows flattening of both the inspiratory and expiratory limbs, which is characteristic of a fixed central airway obstruction. This pattern suggests an obstruction that affects airflow both during inhalation and exhalation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Fixed distal airway obstruction</strong> would not typically affect both phases of the loop.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Variable intrathoracic obstruction</strong> affects the expiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Variable extrathoracic obstruction</strong> affects the inspiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Flattening of both inspiratory and expiratory limbs in a flow-volume loop indicates a fixed central airway obstruction.</span></p>",
    "correct_choice_id": 46099,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50953,
    "choices": [
      {
        "id": 203353,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute HBV infection in window period&nbsp;</span></p>"
      },
      {
        "id": 203354,
        "text": "<p><span style=\"font-size:12.0pt;\">Immune with recombinant HBV Vaccine&nbsp;</span></p>"
      },
      {
        "id": 203355,
        "text": "<p><span style=\"font-size:12.0pt;\">HBV infection in the remote past, completely recovered&nbsp;</span></p>"
      },
      {
        "id": 203356,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic HBV infection inactive carrier&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The blood investigation of a patient is given below. What is the probable diagnosis? (</span>INICET Nov 2023)</p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBs - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive,</span></li><li><span style=\"font-size:12.0pt;\">HBeAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBe \u2013 NR (NR \u2013 Non reactive)</span></li></ul>",
    "unique_key": "Q1615461",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013397,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) HBV infection in the remote past, completely recovered</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's serological markers indicate the following:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - Non-Reactive (NR): This suggests that the patient is not currently infected with Hepatitis B.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBs - NR: Lack of antibodies against the Hepatitis B surface antigen suggests no current immunity from vaccination or recent infection.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR: The absence of IgM antibodies against the core antigen indicates no recent acute infection.</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive: Presence of total core antibodies (including IgG) indicates past exposure to the virus.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBeAg - NR: Absence of the e antigen suggests no active viral replication.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBe - NR: Absence of antibodies against the e antigen suggests no current or recent active infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these markers, the most likely scenario is that the patient had a Hepatitis B infection in the past and has completely recovered. The presence of Anti HBc total (which is predominantly IgG) signifies past infection. In cases of remote past infection, anti-HBs antibodies may fall below detectable levels, although the patient still has immunity through memory B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute HBV infection in window period:&nbsp;</strong>In the window period of acute HBV infection, Anti HBc IgM should be positive, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Immune with recombinant HBV Vaccine:&nbsp;</strong>Patients vaccinated against HBV typically have positive Anti HBs and negative Anti HBc total, as they have not been exposed to the virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic HBV infection inactive carrier:</strong>&nbsp;Chronic HBV infection requires the presence of HBsAg for more than six months. The absence of HBsAg rules out chronic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Anti HBc total (predominantly IgG) with all other markers negative suggests a past HBV infection that has completely resolved.</span></p>",
    "correct_choice_id": 203355,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24768,
    "choices": [
      {
        "id": 99033,
        "text": "<p><span style=\"font-size:11.0pt;\">TPE removes the von Willebrand factor</span></p>"
      },
      {
        "id": 99034,
        "text": "<p><span style=\"font-size:11.0pt;\">TPE removes the antiplatelet antibodies</span></p>"
      },
      {
        "id": 99035,
        "text": "<p><span style=\"font-size:11.0pt;\">TPE replenishes the coagulation factors</span></p>"
      },
      {
        "id": 99036,
        "text": "<p><span style=\"font-size:11.0pt;\">TPE removes anti-ADAMTS13 autoantibodies and thereby increases ADAMTS protease activity</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Total plasma exchange is done in thrombotic thrombocytopenic purpura. How does TPE help in the management of TTP? (INICET MAY 2023)</span></p>",
    "unique_key": "Q1809661",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013398,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;TPE removes anti-ADAMTS13 autoantibodies and thereby increases ADAMTS protease activity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thrombotic thrombocytopenic purpura (TTP) is caused by a deficiency of ADAMTS13, usually due to autoantibodies. Total plasma exchange (TPE) removes these autoantibodies, thereby increasing ADAMTS13 protease activity and preventing the accumulation of large von Willebrand factor multimers. This results in platelet trapping. Classic clinical picture includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Microangiopathic hemolytic anemia (MAHA)</span></li><li><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></li><li><span style=\"font-size:12.0pt;\">End-organ damage (neurological injury)</span></li><li><span style=\"font-size:12.0pt;\">Fever</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. TPE removes the von Willebrand factor</strong>: Incorrect; the goal is to remove autoantibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. TPE removes the antiplatelet antibodies:</strong> Incorrect; TTP involves anti-ADAMTS13 autoantibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. TPE replenishes the coagulation factors:</strong> Incorrect; TTP is not primarily a coagulation factor deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">TPE in TTP primarily removes anti-ADAMTS13 autoantibodies, increasing ADAMTS13 activity and reducing microthrombi formation.</span></p>",
    "correct_choice_id": 99036,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24769,
    "choices": [
      {
        "id": 99037,
        "text": "<p><span style=\"font-size:11.0pt;\">Babinski sign</span></p>"
      },
      {
        "id": 99038,
        "text": "<p><span style=\"font-size:11.0pt;\">Ankle jerk</span></p>"
      },
      {
        "id": 99039,
        "text": "<p><span style=\"font-size:11.0pt;\">Jendrassik</span></p>"
      },
      {
        "id": 99040,
        "text": "<p><span style=\"font-size:11.0pt;\">Normal plantar response</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the sign? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-134049.png\" alt=\"\" width=\"300\" height=\"183\"></span></p>",
    "unique_key": "Q8767494",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013423,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Babinski sign</strong></span></p><p><br><span style=\"font-size:12pt;\">The Babinski sign is a reflex response where the big toe extends upward and the other toes fan out upon stimulation of the sole. This indicates an upper motor neuron lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ankle jerk:</strong> Reflex action at the ankle joint.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Jendrassik:</strong> Maneuver to enhance reflexes.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Normal plantar response:</strong> Flexion of all toes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A positive Babinski sign indicates an upper motor neuron lesion.</span></p>",
    "correct_choice_id": 99037,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47742,
    "choices": [
      {
        "id": 190575,
        "text": "<p>Phenomenon of Raynaud</p>"
      },
      {
        "id": 190576,
        "text": "<p>Nephritis of the tubulointerstitial type</p>"
      },
      {
        "id": 190577,
        "text": "<p>Enlargement of both parotid glands</p>"
      },
      {
        "id": 190578,
        "text": "<p>Development of lymphoma</p>"
      }
    ],
    "text": "<p>Which of the following is NOT considered an extra glandular manifestation of Sjogren's syndrome? (NEET PG 2015)</p>",
    "unique_key": "Q1688147",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013505,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Correct Answer: C. Enlargement of both parotid glands</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Enlargement of the parotid glands is one of the main glandular manifestations of Sj\u00f6gren's syndrome, not an extra-glandular manifestation. Parotid gland enlargement occurs in about two-thirds of patients with primary Sj\u00f6gren's syndrome due to lymphocytic infiltration of the gland. This is considered part of the primary exocrinopathy that characterizes the disease, alongside xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes).</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Phenomenon of Raynaud</strong>: This is a true extra-glandular manifestation of Sj\u00f6gren's syndrome, occurring in approximately 37% of patients. In one-third of patients, it precedes the sicca manifestations and is categorized as a non-specific extra-glandular feature.</p><p>&nbsp;</p><p><strong>Option B. Nephritis of the tubulointerstitial type</strong>: This is a genuine extra-glandular manifestation affecting 9% of Sj\u00f6gren's syndrome patients. It is categorized as a peri-epithelial manifestation, typically asymptomatic, and results from lymphocyte accumulation around renal tubules.</p><p>&nbsp;</p><p><strong>Option D. Development of lymphoma</strong>: This is a serious extra-glandular manifestation occurring in approximately 6% of Sj\u00f6gren's syndrome patients. Glandular MALT lymphoma is most common, with risk factors including persistent parotid enlargement, purpura, leukopenia, cryoglobulinemia, low C4 complement, and certain autoantibodies.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Sj\u00f6gren's syndrome manifestations are classified as either glandular (involving exocrine glands like parotid, lacrimal, and salivary) or extra-glandular (affecting other organ systems including lungs, kidneys, vessels, and nervous system), with the latter occurring in about one-third of patients and determining disease severity.</p>",
    "correct_choice_id": 190577,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11587,
    "choices": [
      {
        "id": 46314,
        "text": "<p><span style=\"font-size:12.0pt;\">Contralateral hemiplegia</span></p>"
      },
      {
        "id": 46315,
        "text": "<p><span style=\"font-size:12.0pt;\">Fasciculation at the level of lesion</span></p>"
      },
      {
        "id": 46316,
        "text": "<p><span style=\"font-size:12.0pt;\">Upper motor neuron lesion and lower motor neuron lesion</span></p>"
      },
      {
        "id": 46317,
        "text": "<p><span style=\"font-size:12.0pt;\">Bladder involvement</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following does not help in the localization of lesions in the spinal cord?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q8666133",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013502,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Contralateral hemiplegia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When localizing lesions in the spinal cord, it is crucial to understand how different tracts and their associated functions are affected:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Corticospinal Tract</strong>: Damage to this tract results in ipsilateral hemiparesis (weakness) below the level of the lesion. This is because the corticospinal tract crosses over (decussates) at the medulla, above the spinal cord. Therefore, damage at the spinal cord level affects the same side of the body.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Posterior Column</strong>: Damage here leads to ipsilateral loss of light touch, vibration, proprioception, and pressure. Similar to the corticospinal tract, the posterior column pathways decussate above the spinal cord.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Spinothalamic Tract</strong>: This tract, responsible for pain and temperature sensation, crosses at the level of the spinal cord itself. Damage to the spinothalamic tract results in contralateral loss of pain and temperature sensation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these pathways, <strong>contralateral hemiplegia</strong> <strong>suggests a lesion above the spinal cord</strong>, typically above the pyramidal decussation in the brainstem or higher. Therefore, it does not help in localizing lesions within the spinal cord itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fasciculation at the level of lesion</strong>: Fasciculations are a sign of lower motor neuron involvement, which can occur at the level of the spinal cord lesion due to damage to the anterior horn cells. This helps in localizing the lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Upper motor neuron lesion and lower motor neuron lesion</strong>: The presence of both upper motor neuron (UMN) and lower motor neuron (LMN) signs can be indicative of a spinal cord lesion. UMN signs (such as spasticity and hyperreflexia) occur below the lesion, while LMN signs (such as fasciculations and muscle atrophy) occur at the level of the lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bladder involvement</strong>: Bladder and bowel dysfunction are common in transverse spinal cord lesions. This is due to the involvement of the autonomic pathways that control these functions, helping to localize the lesion within the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Contralateral hemiplegia indicates a lesion above the spinal cord, specifically above the level of pyramidal decussation.</span></p>",
    "correct_choice_id": 46314,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20261,
    "choices": [
      {
        "id": 81005,
        "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
      },
      {
        "id": 81006,
        "text": "<p><span style=\"font-size:12.0pt;\">Squatting</span></p>"
      },
      {
        "id": 81007,
        "text": "<p><span style=\"font-size:12.0pt;\">Valsalva</span></p>"
      },
      {
        "id": 81008,
        "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following would most likely lead to a decrease in the intensity of the murmur in a patient with hypertrophic cardiomyopathy? (NEET PG 2023)</span></p>",
    "unique_key": "Q9642752",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013411,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Squatting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hypertrophic cardiomyopathy (HCM), the intensity of the murmur is influenced by the left ventricular outflow tract (LVOT) obstruction. Various maneuvers and medications can affect this obstruction by altering preload (the volume of blood in the ventricles before contraction) or afterload (the resistance the heart must pump against).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Squatting</strong> increases preload by squeezing the peripheral veins and increasing venous return to the heart. This increase in preload reduces LVOT obstruction, thereby decreasing the murmur's intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Digoxin:</strong> Digoxin increases contractility. In HCM, increased contractility can worsen LVOT obstruction, thereby increasing the intensity of the murmur and worsening the murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Valsalva</strong>: The Valsalva maneuver reduces preload by decreasing venous return to the heart. This reduction in preload can increase LVOT obstruction, leading to a louder murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Furosemide</strong>: By reducing preload, furosemide increases LVOT obstruction and murmur intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Increasing preload (e.g., through squatting) reduces LVOT obstruction in hypertrophic cardiomyopathy, leading to a decrease in the murmur's intensity.</span></p>",
    "correct_choice_id": 81006,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84282,
    "choices": [
      {
        "id": 335704,
        "text": "<p><span style=\"font-size:12.0pt;\">The presence of contralateral mediastinal lymph nodes precludes surgical resection</span></p>"
      },
      {
        "id": 335705,
        "text": "<p><span style=\"font-size:12.0pt;\">For patients over 70 years with advanced disease, single-agent chemotherapy is preferred</span></p>"
      },
      {
        "id": 335706,
        "text": "<p><span style=\"font-size:12.0pt;\">Among the Asian population, squamous cell carcinoma is the most common type of NSCLC</span></p>"
      },
      {
        "id": 335707,
        "text": "<p><span style=\"font-size:12.0pt;\">Gefitinib shows the highest efficacy in female smokers with adenocarcinoma</span></p>"
      }
    ],
    "text": "<p>All of the following statements regarding Non-Small Cell Lung Carcinoma (NSCLC) are accurate, except: (NEET PG 2016)</p>",
    "unique_key": "Q1970026",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013404,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. C) Among the Asian population, squamous cell carcinoma is the most common type of NSCLC</strong></p><p>&nbsp;</p><p>In Asian populations, adenocarcinoma (not squamous cell carcinoma) is the most common histologic type of NSCLC. This demographic pattern is important because it correlates with the higher prevalence of EGFR mutations observed in Asian patients, which has significant implications for treatment selection and response to targeted therapies.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. The presence of contralateral mediastinal lymph nodes precludes surgical resection</strong>: Contralateral mediastinal lymph node involvement (N3 disease) indicates stage IIIB disease, which is generally considered unresectable. This represents locally advanced disease where surgery would not provide survival benefit.</p><p>&nbsp;</p><p><strong>Option B. For patients over 70 years with advanced disease, single-agent chemotherapy is preferred</strong>: For elderly patients (&gt;70 years) with advanced NSCLC, single-agent chemotherapy is often preferred due to reduced toxicity while maintaining modest efficacy. This approach provides a better risk-benefit ratio in this population.</p><p>&nbsp;</p><p><strong>Option D. Gefitinib shows the highest efficacy in female smokers with adenocarcinoma</strong>: This statement is incorrect. Gefitinib, an EGFR tyrosine kinase inhibitor, shows highest efficacy in female NON-smokers with adenocarcinoma histology. Smoking status is a critical negative predictor of response to EGFR inhibitors.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The epidemiology of NSCLC varies by population, with adenocarcinoma being the predominant subtype in Asian populations, associated with higher rates of EGFR mutations that impact therapeutic approaches and response to targeted therapies.</p>",
    "correct_choice_id": 335706,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11267,
    "choices": [
      {
        "id": 45034,
        "text": "<p><span style=\"font-size:12.0pt;\">Non-Invasive PPV should be given</span></p>"
      },
      {
        "id": 45035,
        "text": "<p><span style=\"font-size:12.0pt;\">Invasive PPV should be given</span></p>"
      },
      {
        "id": 45036,
        "text": "<p><span style=\"font-size:12.0pt;\">IV corticosteroids should be administered</span></p>"
      },
      {
        "id": 45037,
        "text": "<p><span style=\"font-size:12.0pt;\">Permissive hypercapnia is allowed</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old male patient who is a known case of COPD presented with acute exacerbation and in type 2 respiratory failure was admitted to the ICU. Which of the following statements is correct with regards to the initial management of this patient? (NEET PG 2020)</span></p>",
    "unique_key": "Q8495853",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013383,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Non-Invasive PPV should be given</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Non-Invasive Positive Pressure Ventilation (NIPPV) is often the initial treatment of choice for patients with COPD who present with an acute exacerbation and are in type 2 respiratory failure (characterized by hypercapnia and respiratory acidosis). NIPPV can improve gas exchange and reduce the work of breathing without the need for endotracheal intubation, thereby decreasing the risk of infection and other complications associated with invasive mechanical ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Invasive Positive Pressure Ventilation (IPPV):</strong> This is generally reserved for patients who fail NIPPV or present with severe acidosis, hemodynamic instability, or decreased level of consciousness that precludes the use of NIPPV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IV corticosteroids:</strong> While systemic corticosteroids are commonly used in the management of acute COPD exacerbations, the initial focus in a patient in respiratory failure should be on stabilizing the patient's breathing and gas exchange. Corticosteroids can be administered orally or intravenously, but this would not be the primary concern in the immediate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -</strong> Oral steroids (prednisolone) is given for 5-14 days in acute exacerbations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Permissive hypercapnia:</strong> This is a strategy used in mechanical ventilation where slightly elevated levels of carbon dioxide (hypercapnia) are tolerated to avoid high ventilatory pressures that can lead to lung injury, however pH is maintained above 7.3. It is applicable during mechanical ventilation if it becomes necessary but is not an initial management step.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a COPD patient presenting with acute exacerbation and respiratory failure, non-invasive ventilation is the preferred initial management strategy to stabilize the patient's respiratory status, reducing the need for intubation and potentially improving clinical outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Pulmonology/COPD/chapter 292</strong></span></p>",
    "correct_choice_id": 45034,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73075,
    "choices": [
      {
        "id": 291265,
        "text": "<p><span style=\"font-size:16px;\">Guillain-Barr\u00e9 Syndrome (GBS)</span></p>"
      },
      {
        "id": 291266,
        "text": "<p><span style=\"font-size:16px;\">Transverse myelitis</span></p>"
      },
      {
        "id": 291267,
        "text": "<p><span style=\"font-size:16px;\">Myasthenia gravis</span></p>"
      },
      {
        "id": 291268,
        "text": "<p><span style=\"font-size:16px;\">Multiple sclerosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A patient presents with progressive weakness that started in his lower limbs and is now ascending to involve his upper limbs. Examination reveals absent reflexes in the affected limbs and no significant sensory deficits. He had an upper respiratory tract infection two weeks ago. What is the most likely diagnosis? (FMGE JAN 2025)</span></p>",
    "unique_key": "Q6069122",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013418,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Guillain-Barr\u00e9 Syndrome (GBS)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The diagnosis of <strong>GBS</strong> is supported by the classic <strong>triad of symptoms</strong> known as the <strong>\"three A's\"</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Acute onset</strong></span></li><li><span style=\"font-size:16px;\"><strong>Ascending paralysis</strong> (starting in the lower limbs and progressing upwards)</span></li><li><span style=\"font-size:16px;\"><strong>Areflexia</strong> (absent reflexes)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Additional supporting features include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Recent upper respiratory tract infection</strong> (<strong>often Mycoplasma pneumoniae</strong>)</span></li><li><span style=\"font-size:16px;\"><strong>Symmetrical weakness</strong></span></li><li><span style=\"font-size:16px;\"><strong>Relative preservation of sensory function</strong></span></li><li><span style=\"font-size:16px;\"><strong>Post-infectious immune-mediated process</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">(If the patient had a history of <strong>diarrhea</strong>, the most likely pathogen would be <strong>Campylobacter jejuni</strong>.)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Transverse myelitis:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Usually has <strong>bladder/bowel involvement</strong></span></li><li><span style=\"font-size:16px;\">Reflexes may be <strong>increased below the lesion</strong>, not absent</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Myasthenia gravis:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Causes <strong>descending weakness</strong>, often affecting <strong>ocular and bulbar muscles</strong> first</span></li><li><span style=\"font-size:16px;\"><strong>Normal reflexes</strong> and <strong>fluctuating weakness with fatigue</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Multiple sclerosis:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Presents with <strong>upper motor neuron signs</strong> (hyperreflexia, Babinski sign)</span></li><li><span style=\"font-size:16px;\">Often associated with <strong>optic neuritis and sensory symptoms</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Guillain-Barr\u00e9 Syndrome (GBS) should be suspected in a patient with acute, ascending areflexic paralysis, particularly following a recent infection.</span></p>",
    "correct_choice_id": 291265,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 48801,
    "choices": [
      {
        "id": 194787,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory</span></span></p>"
      },
      {
        "id": 194788,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Demyelinating</span></span></p>"
      },
      {
        "id": 194789,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Descending</span></span></p>"
      },
      {
        "id": 194790,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cranial nerve involvement</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the following statements about Guillain-Barre Syndrome are true, except? (NEET PG 2017)</span></span></span></p>",
    "unique_key": "Q1816631",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013405,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.&nbsp;</span></em></strong><strong><span style=\"font-size:12.0pt\">C. Descending</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Guillain-Barre Syndrome (GBS) is an acute autoimmune condition characterized by inflammation and demyelination of peripheral nerves and nerve roots (polyradiculopathy). The hallmark feature of GBS is an ascending paralysis, meaning that the weakness typically starts in the lower limbs and progresses upwards. This ascending pattern differentiates GBS from conditions with a descending pattern of paralysis. GBS often follows an infection, with Campylobacter jejuni being a common antecedent. Other features of GBS include cranial nerve involvement, autonomic dysfunction, and albuminocytologic dissociation in cerebrospinal fluid (CSF).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Inflammatory</span></strong><span style=\"font-size:12.0pt\">: Correct. GBS is an inflammatory condition.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Demyelinating</span></strong><span style=\"font-size:12.0pt\">: Correct. GBS involves demyelination of peripheral nerves.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Cranial nerve involvement</span></strong><span style=\"font-size:12.0pt\">: Correct. Cranial nerves are often affected in GBS.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Guillain-Barre Syndrome is typically characterized by ascending paralysis, not descending.</span></span></span></p>",
    "correct_choice_id": 194789,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11276,
    "choices": [
      {
        "id": 45070,
        "text": "<p><span style=\"font-size:12.0pt;\">Necrotizing inflammation of large vessels</span></p>"
      },
      {
        "id": 45071,
        "text": "<p><span style=\"font-size:12.0pt;\">Patient has hypogammaglobulinemia</span></p>"
      },
      {
        "id": 45072,
        "text": "<p><span style=\"font-size:12.0pt;\">90% is associated with ANCA positivity</span></p>"
      },
      {
        "id": 45073,
        "text": "<p><span style=\"font-size:12.0pt;\">30% is associated with Hepatitis B</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about polyarteritis nodosa? (NEET PG 2020)</span></p>",
    "unique_key": "Q8887469",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013408,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 30% association with Hepatitis B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis predominantly affecting medium-sized arteries, often associated with Hepatitis B in about 30% of cases. The association with Hepatitis B is significant because the virus can trigger immune complex deposition, contributing to vascular inflammation and damage characteristic of PAN.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Necrotizing inflammation of large vessels:&nbsp;</strong>This is incorrect because PAN specifically affects medium-sized, not large vessels. Large vessel vasculitis includes conditions like Giant Cell Arteritis and Takayasu Arteritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Patient has hypogammaglobulinemia:&nbsp;</strong>This is incorrect; PAN is often associated with hypergammaglobulinemia due to chronic immune activation, not hypogammaglobulinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 90% is associated with ANCA positivity:&nbsp;</strong>This statement is also incorrect. Polyarteritis nodosa is typically ANCA-negative; the presence of ANCA is more characteristic of other forms of vasculitis such as Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-104010.jpg\" alt=\"\" width=\"1000\" height=\"772\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Vasculitis/Chap 363</strong></span></p>",
    "correct_choice_id": 45073,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54267,
    "choices": [
      {
        "id": 216537,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
      },
      {
        "id": 216538,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 2 and 4</span></p>"
      },
      {
        "id": 216539,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4 and 2</span></p>"
      },
      {
        "id": 216540,
        "text": "<p><span style=\"font-size:12.0pt;\">4, 2, 1 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Many GPCR receptors act via an increase in cAMP. The steps involved in this mechanism are given below. Which of the following is the correct sequence of events in the cAMP signal transduction pathway?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Activation of adenylate cyclase</span></li><li><span style=\"font-size:12.0pt;\">Activation of PKA</span></li><li><span style=\"font-size:12.0pt;\">Conversion of ATP to cAMP</span></li><li><span style=\"font-size:12.0pt;\">Phosphorylation of target proteins</span></li></ol>",
    "unique_key": "Q3165755",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013421,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 3, 2 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G protein-coupled receptors (GPCRs) that act via an increase in cyclic AMP (cAMP) follow a specific sequence of events in the signal transduction pathway. The steps involved are as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Activation of Adenylate Cyclase:</strong> Upon ligand binding to the G-stimulatory GPCR, the receptor activates adenylate cyclase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Conversion of ATP to cAMP:</strong> The activated adenylate cyclase converts ATP to cyclic AMP (cAMP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Activation of Protein Kinase A (PKA):</strong> The increased levels of cAMP activate protein kinase A (PKA).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Phosphorylation of Target Proteins:</strong> PKA then phosphorylates various target proteins, leading to the desired cellular response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This sequence of events accurately describes the cAMP signal transduction pathway activated by G-stimulatory GPCRs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of events in the cAMP signal transduction pathway activated by G-stimulatory GPCRs is: Activation of adenylate cyclase, conversion of ATP to cAMP, activation of PKA, and phosphorylation of target proteins.</span></p>",
    "correct_choice_id": 216538,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11242,
    "choices": [
      {
        "id": 44934,
        "text": "<p><span style=\"font-size:12.0pt;\">Encephalopathy attributed to HIV</span></p>"
      },
      {
        "id": 44935,
        "text": "<p><span style=\"font-size:12.0pt;\">Invasive cervical cancer</span></p>"
      },
      {
        "id": 44936,
        "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis of any site</span></p>"
      },
      {
        "id": 44937,
        "text": "<p><span style=\"font-size:12.0pt;\">Oral candidiasis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following are AIDS defining illnesses except: (NEET PG 2019)</span></p>",
    "unique_key": "Q4046047",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013509,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Oral Candidiasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Oral candidiasis, while commonly associated with HIV infection, is not itself an AIDS-defining illness. The Centers for Disease Control and Prevention (CDC) list of AIDS-defining illnesses includes more severe manifestations such as candidiasis of the esophagus, trachea, bronchi, or lungs, but not oral candidiasis. This fungal infection is often seen in patients with HIV as a marker of immune suppression but does not qualify as an indicator of AIDS on its own.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Encephalopathy attributed to HIV:</strong> This is an AIDS-defining condition, as it represents a direct effect of HIV on the brain resulting in cognitive impairment and motor dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Invasive cervical cancer:</strong> This is considered an AIDS-defining illness due to the high risk and prevalence of this cancer in individuals with advanced HIV, reflecting a significant degree of immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycobacterium tuberculosis of any site:</strong> Tuberculosis, whether pulmonary or extrapulmonary, is an AIDS-defining illness due to its severity and frequency in the context of HIV-induced immune suppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-110710.jpg\" alt=\"\" width=\"1000\" height=\"359\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Infectious Disease/Chap 202</strong></span></p>",
    "correct_choice_id": 44937,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92153,
    "choices": [
      {
        "id": 366928,
        "text": "<p><span style=\"font-size:14.0pt;\">Packed Red Blood Cells</span></p>"
      },
      {
        "id": 366929,
        "text": "<p><span style=\"font-size:14.0pt;\">Fresh Frozen Plasma</span></p>"
      },
      {
        "id": 366930,
        "text": "<p><span style=\"font-size:14.0pt;\">Dextran 40</span></p>"
      },
      {
        "id": 366931,
        "text": "<p><span style=\"font-size:14.0pt;\">Albumin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">According to the Muir-Barclay formula, which of the following is considered the primary fluid for volume replacement? (INICET MAY 2025)</span></p>",
    "unique_key": "Q8010784",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013419,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Muir-Barclay formula is specifically designed to calculate the amount of albumin required for replacement in patients with severe hypoalbuminemia, particularly in burn patients. The formula originated from the UK and was primarily devised for albumin replacement.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Formula:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>(Desired albumin level - Actual serum albumin) \u00d7 Body weight in kg \u00d7 2</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For example, if desired albumin is 3.5 g/dL, actual albumin is 2 g/dL, and patient weighs 60 kg,&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Then: (3.5-2) \u00d7 60 \u00d7 2 = 180 grams of albumin to be given over 1-2 days.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">While there are many other fluid replacement formulas for different clinical scenarios (like Parkland formula for burns, Evans formula, etc.), the Muir-Barclay formula specifically addresses albumin replacement for hypoalbuminemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Packed Red Blood Cells:</strong> PRBCs are used for correcting anemia and blood loss, not for volume replacement calculations in the Muir-Barclay formula.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fresh Frozen Plasma:</strong> FFP is used for coagulation factor replacement, not as the primary fluid in the Muir-Barclay formula.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dextran 40:</strong> Dextran is a colloid solution used for volume expansion but is not the primary fluid calculated by the Muir-Barclay formula.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Muir-Barclay formula is specifically used to calculate albumin requirements for volume replacement in patients with severe hypoalbuminemia, particularly in burn patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Burns Fluid Resuscitation Formulas</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tqAbVja.png\" width=\"978\" height=\"477\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pediatric Fluid Resuscitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Ra9kxSM.png\" width=\"1165\" height=\"537\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Sepsis &amp; Shock Fluid Resuscitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_UIjQ8vU.png\" width=\"979\" height=\"164\"></strong></span></p>",
    "correct_choice_id": 366931,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92153/Ini_Cet_May_2025_Medicine_Q_-_14new.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [
      "CriteriaBased",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92153/Ini_Cet_May_2025_Medicine_Q_-_14new.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16300,
    "choices": [
      {
        "id": 65160,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endotracheal intubation</span></span></span></p>"
      },
      {
        "id": 65161,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Invasive positive pressure ventilation (IPPV)</span></span></span></p>"
      },
      {
        "id": 65162,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-invasive positive pressure ventilation (NIPPV)</span></span></span></p>"
      },
      {
        "id": 65163,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lung Volume reduction surgery</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old man with a history of COPD presents with sudden onset increased shortness of breath. His ABG analysis reveals pH - 7.27, pCO2 - 60 mm Hg, pO2 - 52 mmHg, and HCO3 - 27 mmol/L. What is the most appropriate treatment for this patient? (FMGE DEC 2021)</span></span></span></p>",
    "unique_key": "Q4348965",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013412,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Non-invasive positive pressure ventilation (NIPPV)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Given the patient&#39;s PO2 of 52 (which is less than 60), it indicates respiratory failure. With elevated CO2 levels and low oxygen, this suggests <strong>Type 2 respiratory failure</strong>. This type of respiratory failure is characterized by both low oxygen and high carbon dioxide levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Since the bicarbonate level is 27 (which is not elevated beyond 30), this suggests <strong>acute</strong> respiratory failure rather than chronic, as chronic respiratory failure would typically show higher bicarbonate levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For treatment, if the pH is less than or equal to 7.35 and the PaCO2 is 45 mmHg or higher, <strong>Non-Invasive Positive Pressure Ventilation (NIPPV)</strong> can be considered, provided there are no contraindications. One significant contraindication for NIPPV is altered sensorium, particularly if the Glasgow Coma Scale (GCS) is very low.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, if the pH is less than 7.25, indicating severe acidosis, NIPPV may have a high failure rate. In such cases, <strong>endotracheal intubation</strong> is recommended instead of NIPPV, as severe acidosis significantly increases the risk of NIPPV failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the setting of acute exacerbation of COPD, the Non-Invasive Positive Pressure Ventilation (NIPPV) of choice is <strong>BiPAP (Bi-Level Positive Airway Pressure)</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Endotracheal intubation:</span></strong><span style=\"font-size:12.0pt\"> Reserved for severe cases not responding to NIPPV or if the patient is unable to protect their airway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Invasive positive pressure ventilation (IPPV):</span></strong><span style=\"font-size:12.0pt\"> More invasive than NIPPV and used if NIPPV fails.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Lung Volume reduction surgery:</span></strong><span style=\"font-size:12.0pt\"> Not an acute intervention and used for long-term management in selected patients with severe COPD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NIPPV is indicated for acute exacerbations of COPD with respiratory acidosis.</span></span></span></p>",
    "correct_choice_id": 65162,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11372,
    "choices": [
      {
        "id": 45454,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lateral pontine syndrome</span></span></span></p>"
      },
      {
        "id": 45455,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medial medullary syndrome</span></span></span></p>"
      },
      {
        "id": 45456,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lateral medullary syndrome</span></span></span></p>"
      },
      {
        "id": 45457,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Locked-In Syndrome</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 46-year-old male presents to the ER with the acute onset of ataxia. Neurological examination shows loss of pain and temperature sensation from the face on the left side and loss of pain and temperature sensation from the right half of the body. He also has dysarthria, dysphagia, and diminished gag reflex with ptosis, miosis, and anhidrosis on the left. What is the most likely diagnosis? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q6402137",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013385,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Lateral medullary syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation with loss of pain and temperature sensation from the left side of the face and the right side of the body, along with dysarthria, dysphagia, and diminished gag reflex, suggests involvement of the lateral medulla. Additionally, the presence of Horner&#39;s syndrome (ptosis, miosis, and anhidrosis) on the left side further supports this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lateral medullary syndrome, also known as <strong>Wallenberg syndrome</strong>, typically results from occlusion of the vertebral artery or the <strong>posterior inferior cerebellar artery (PICA).</strong> The key clinical features include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ipsilateral loss of pain and temperature sensation in the face</span></strong><span style=\"font-size:12.0pt\"> due to involvement of the spinal trigeminal nucleus.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Contralateral loss of pain and temperature sensation in the body</span></strong><span style=\"font-size:12.0pt\"> due to involvement of the spinothalamic tract.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dysarthria and dysphagia</span></strong><span style=\"font-size:12.0pt\"> due to involvement of the nucleus ambiguus (cranial nerves IX and X).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ipsilateral Horner&#39;s syndrome</span></strong><span style=\"font-size:12.0pt\"> due to disruption of the descending sympathetic pathways.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ataxia</span></strong><span style=\"font-size:12.0pt\"> due to involvement of the inferior cerebellar peduncle.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Lateral pontine syndrome</strong>: Lateral pontine syndrome involves the pons and typically affects cranial nerves that are not involved in this patient&#39;s presentation. For example, it often involves the facial nerve (cranial nerve VII), leading to facial weakness, which is not described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Medial medullary syndrome</span></strong><span style=\"font-size:12.0pt\">: Medial medullary syndrome affects the medial structures of the medulla, including the hypoglossal nerve (cranial nerve XII), and results in ipsilateral tongue weakness and contralateral hemiparesis. This does not match the patient&#39;s symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Locked-In Syndrome</span></strong><span style=\"font-size:12.0pt\">: Locked-In Syndrome results from bilateral lesions in the ventral pons, leading to quadriplegia and anarthria, but with preserved consciousness and vertical eye movements. The patient&#39;s symptoms do not align with this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lateral medullary syndrome (Wallenberg syndrome) is characterized by ipsilateral loss of pain and temperature sensation in the face, contralateral loss of pain and temperature sensation in the body, dysarthria, dysphagia, and ipsilateral Horner&#39;s syndrome.</span></span></p>",
    "correct_choice_id": 45456,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11327,
    "choices": [
      {
        "id": 45274,
        "text": "<p><span style=\"font-size:12.0pt;\">Add intravenous enalaprilat</span></p>"
      },
      {
        "id": 45275,
        "text": "<p><span style=\"font-size:12.0pt;\">Increase nitroprusside infusion</span></p>"
      },
      {
        "id": 45276,
        "text": "<p><span style=\"font-size:12.0pt;\">Repair the descending aorta</span></p>"
      },
      {
        "id": 45277,
        "text": "<p><span style=\"font-size:12.0pt;\">Switch nitroprusside to amlodipine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman with a recent type B aortic dissection presents with abdominal pain and lower limb ischemia with diminished femoral and popliteal pulses. What is the most appropriate next step?</span></p>",
    "unique_key": "Q2369929",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013409,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Repair the descending aorta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">New-onset abdominal pain and limb ischemia in a patient with type B aortic dissection indicate a complicated dissection, likely due to malperfusion of the mesenteric and lower extremity arteries. This requires urgent surgical or endovascular repair.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Enalaprilat:</strong> Although used for blood pressure control, it doesn't address the underlying issue of malperfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increasing nitroprusside:</strong> May help with blood pressure control but doesn't solve the urgent need for revascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. &nbsp;Switching to amlodipine:</strong> Not appropriate in an acute setting requiring immediate intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the signs of complicated type B aortic dissection (malperfusion syndromes) and the need for immediate surgical/endovascular repair.</span></p>",
    "correct_choice_id": 45276,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54266,
    "choices": [
      {
        "id": 216533,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus Nephritis</span></span></p>"
      },
      {
        "id": 216534,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Venous Insufficiency</span></span></p>"
      },
      {
        "id": 216535,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart Failure</span></span></p>"
      },
      {
        "id": 216536,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Liver Disease</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is the least common cause of bipedal edema?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q4656874",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013396,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Chronic Venous Insufficiency</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic venous insufficiency (CVI) typically leads to asymmetric leg swelling, where one leg is more affected than the other. In cases of CVI, the swelling is often unilateral, and if bilateral, it is usually asymmetric. This makes it the least common cause of bipedal (symmetric) edema among the given options.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Lupus Nephritis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition affects the kidneys, leading to fluid retention and typically causing bilateral leg swelling. It is a common cause of symmetric bipedal edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Heart Failure:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This systemic condition causes the heart to pump blood inefficiently, leading to fluid buildup in the lower extremities and symmetric bipedal edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Chronic Liver Disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition results in decreased protein synthesis and portal hypertension, causing fluid retention and symmetric bipedal edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic venous insufficiency typically causes unilateral or asymmetric leg swelling, making it the least common cause of symmetric bipedal edema.</span></span></span></p>",
    "correct_choice_id": 216534,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73074,
    "choices": [
      {
        "id": 291261,
        "text": "<p><span style=\"font-size:16px;\">Adenosine</span></p>"
      },
      {
        "id": 291262,
        "text": "<p><span style=\"font-size:16px;\">Amiodarone</span></p>"
      },
      {
        "id": 291263,
        "text": "<p><span style=\"font-size:16px;\">Metoprolol</span></p>"
      },
      {
        "id": 291264,
        "text": "<p><span style=\"font-size:16px;\">Verapamil</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old woman presents to the emergency department with palpitations, dizziness, and mild shortness of breath. Her ECG shows a narrow complex tachycardia with a regular rhythm, consistent with supraventricular tachycardia (SVT). Her blood pressure is stable. What is the first-line drug of choice for treating this condition? (FMGE JAN 2025)</span></p>",
    "unique_key": "Q4457254",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013393,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In a <strong>hemodynamically stable</strong> patient with <strong>supraventricular tachycardia (SVT)</strong>, <strong>adenosine</strong> is the <strong>first-line pharmacological treatment</strong> after attempting <strong>vagal maneuvers</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Adenosine is preferred because:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Extremely short half-life (8-10 seconds)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Effectively terminates most forms of SVT</strong> by <strong>blocking AV nodal conduction</strong></span></li><li><span style=\"font-size:16px;\"><strong>Administered as a rapid IV push (6 mg initial dose, followed by 12 mg if needed)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Amiodarone:</strong> Not first-line therapy for acute SVT. More commonly used for <strong>ventricular arrhythmias or refractory SVT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Metoprolol:</strong> Effective for rate control in <strong>AF</strong>, but <strong>not the first choice for acute SVT termination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Verapamil:</strong> Used for <strong>SVT treatment</strong>, but <strong>not first-line</strong> due to <strong>risk of hypotension and bradycardia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Adenosine is the first-line treatment</strong> for <strong>hemodynamically stable supraventricular tachycardia (SVT)</strong>, administered as a <strong>rapid IV push</strong> following vagal maneuvers.</span></p>",
    "correct_choice_id": 291261,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74888,
    "choices": [
      {
        "id": 298449,
        "text": "<p><span style=\"font-size:16px;\">Ustekinumab</span></p>"
      },
      {
        "id": 298450,
        "text": "<p><span style=\"font-size:16px;\">Etanercept</span></p>"
      },
      {
        "id": 298451,
        "text": "<p><span style=\"font-size:16px;\">Vedolizumab</span></p>"
      },
      {
        "id": 298452,
        "text": "<p><span style=\"font-size:16px;\">Tofacitinib</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which JAK inhibitor drug is recommended for moderate to severe ulcerative colitis in a patient who is not responding well to TNF-alpha blockers? (INICET NOV 2024)</span></p>",
    "unique_key": "Q4669499",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013395,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Tofacitinib</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Tofacitinib is a JAK (Janus Kinase) inhibitor that is specifically approved for treating moderate to severe ulcerative colitis in patients who have failed or are not responding to TNF-alpha blockers. It represents a different mechanism of action compared to TNF-alpha inhibitors, making it a suitable alternative for patients who have failed anti-TNF therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Ustekinumab:</strong> Incorrect. While it can be used in inflammatory bowel disease, it is a combined anti-IL-12 and IL-23 blocker, not a JAK inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Etanercept:</strong> Incorrect. This is an anti-TNF drug, and the question specifically asks about patients who are not responding to TNF-alpha blockers.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Vedolizumab:</strong> Incorrect. This is an \u03b14\u03b27 integrin blocker used in IBD, but not a JAK inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Tofacitinib is the JAK inhibitor approved for moderate to severe ulcerative colitis in patients who have failed TNF-alpha blockers. Other JAK inhibitors used in rheumatological diseases include baricitinib and upadacitinib.</span></p>",
    "correct_choice_id": 298452,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11760,
    "choices": [
      {
        "id": 47006,
        "text": "<p><span style=\"font-size:12.0pt;\">Congestive heart failure</span></p>"
      },
      {
        "id": 47007,
        "text": "<p><span style=\"font-size:12.0pt;\">Budd Chiari syndrome</span></p>"
      },
      {
        "id": 47008,
        "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
      },
      {
        "id": 47009,
        "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">50 yr old gentleman presented with progressive abdominal distension with shifting dullness on examination and dilated veins on lateral chest wall. Ascitic fluid analysis given below. What is the likely diagnosis? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105207.png\" alt=\"\" width=\"1000\" height=\"462\"></span></p>",
    "unique_key": "Q2895738",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013504,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Budd-Chiari syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Presence of lateral dilated veins with high SAAG, low protein suggests Late Budd-Chiari syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SAAG=Serum albumin- Ascitic Albumin = 2g/dl</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Interpretation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">\u22651.1: Portal Hypertension (Transudate)</span></li><li><span style=\"font-size:12.0pt;\">&lt;1.1: Exudate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ascitic fluid protein helps identify sinusoidal vs non-sinusoidal causes</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Ascitic fluid protein &gt;2.5 = non-sinusoidal&nbsp;&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Congestive Heart Failure</strong>: Typically presents with high SAAG and high protein content in the ascitic fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cirrhosis</strong>: While cirrhosis can also present with high SAAG, it usually shows low protein content in the ascitic fluid, which aligns with this case, but the presence of dilated veins specific to Budd-Chiari provides a more accurate diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tuberculosis</strong>: Tuberculous peritonitis typically presents with a low SAAG and high protein content, which is inconsistent with the findings in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105251.png\" alt=\"\" width=\"1000\" height=\"350\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hepatology/ascites</strong></span></p>",
    "correct_choice_id": 47007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50955,
    "choices": [
      {
        "id": 203361,
        "text": "<p><span style=\"font-size:12.0pt;\">Anosmia&nbsp;</span></p>"
      },
      {
        "id": 203362,
        "text": "<p><span style=\"font-size:12.0pt;\">Syndactyly in males&nbsp;</span></p>"
      },
      {
        "id": 203363,
        "text": "<p><span style=\"font-size:12.0pt;\">Precocious puberty in females&nbsp;</span></p>"
      },
      {
        "id": 203364,
        "text": "<p><span style=\"font-size:12.0pt;\">White forelock&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most characteristic feature of Kallmann syndrome? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p>",
    "unique_key": "Q8306528",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013422,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Anosmia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kallmann syndrome is a genetic condition characterized by the failure to start or fully complete puberty and an impaired sense of smell (anosmia). It results from an isolated deficiency of gonadotropin-releasing hormone (GnRH), leading to low levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and consequently, hypogonadotropic hypogonadism. Anosmia is the hallmark feature of Kallmann syndrome and helps differentiate it from other causes of hypogonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Syndactyly in males:&nbsp;</strong>This refers to the fusion of fingers or toes and is not characteristic of Kallmann syndrome.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Precocious puberty in females:&nbsp;</strong>This is an early onset of puberty, which is not associated with Kallmann syndrome, as this condition causes delayed or absent puberty.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. White forelock:&nbsp;</strong>This is a feature of Waardenburg syndrome, not Kallmann syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anosmia is the most characteristic feature of Kallmann syndrome, which is associated with hypogonadotropic hypogonadism due to isolated GnRH deficiency.</span></p>",
    "correct_choice_id": 203361,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55358,
    "choices": [
      {
        "id": 220893,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Add budesonide with monitoring of plasma levels of these drugs</span></span></p>"
      },
      {
        "id": 220894,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Monitor plasma levels of ipratropium and formoterol</span></span></p>"
      },
      {
        "id": 220895,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Use a spacer device</span></span></p>"
      },
      {
        "id": 220896,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Switch to oral corticosteroids</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 50-year-old male patient with bronchial asthma is currently on inhaler therapy with ipratropium and formoterol. Despite the medication, his symptoms are not improving due to hand-mouth incoordination. What should be the next step in management? (FMGE JULY 2024)</span></span></p>",
    "unique_key": "Q5326507",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013392,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Use a spacer device</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In patients with bronchial asthma, effective delivery of inhaled medications is crucial for symptom control. When a patient experiences hand-mouth incoordination, they may not be able to use their inhaler correctly, leading to poor drug delivery and inadequate symptom control. A spacer device helps overcome this issue by simplifying the inhalation process, ensuring better delivery of the medication to the lungs. The spacer holds the medication released from the inhaler, allowing the patient to inhale it slowly and more effectively, improving the coordination between actuation and inhalation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Add budesonide with monitoring of plasma levels of these drugs:</strong> Adding budesonide, an inhaled corticosteroid, might help in controlling asthma symptoms, but it does not address the fundamental problem of hand-mouth incoordination. Monitoring plasma levels is generally unnecessary for inhaled medications in this context.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Monitor plasma levels of ipratropium and formoterol:</strong> Monitoring plasma levels of inhaled medications is not a standard practice and does not address the issue of poor inhaler technique due to hand-mouth incoordination.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Switch to oral corticosteroids:</strong> While oral corticosteroids can be effective for severe asthma exacerbations, they have significant side effects and are not a preferred long-term solution for managing chronic asthma symptoms due to poor inhaler technique.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">For asthma patients with hand-mouth incoordination, using a spacer device is an effective solution to improve medication delivery and symptom control.</span></span></p>",
    "correct_choice_id": 220895,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20256,
    "choices": [
      {
        "id": 80985,
        "text": "<p><span style=\"font-size:12.0pt;\">Bumetanide</span></p>"
      },
      {
        "id": 80986,
        "text": "<p><span style=\"font-size:12.0pt;\">Ethacrynic acid</span></p>"
      },
      {
        "id": 80987,
        "text": "<p><span style=\"font-size:12.0pt;\">Nesiritide</span></p>"
      },
      {
        "id": 80988,
        "text": "<p><span style=\"font-size:12.0pt;\">Mannitol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient with hyperkalemia and elevated urea levels underwent dialysis. Towards the end of the session, she became drowsy and had a sudden seizure episode. On examination, the patient was hypotensive. What is the treatment for this condition? (NEET PG 2023)</span></p>",
    "unique_key": "Q1882201",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013386,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D. Mannitol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is experiencing <strong>Dialysis Disequilibrium Syndrome (DDS</strong>), a complication that can occur during or after hemodialysis, especially in patients with <strong>initially very high urea levels</strong> undergoing dialysis for the first time. DDS is caused by a rapid decrease in urea levels in the blood, leading to a sudden change in osmolarity, which causes water to move into the cells, resulting in cerebral edema and neurological symptoms such as drowsiness and seizures.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Dialysis Disequilibrium Syndrome (DDS):</strong> This condition is characterized by neurological symptoms due to cerebral edema caused by rapid changes in blood urea levels during dialysis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mannitol:</strong> This osmotic diuretic is used to treat cerebral edema by reducing intracranial pressure and drawing fluid out of the brain cells, thus decreasing cerebral edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bumetanide:</strong> This loop diuretic is used for fluid overload but not specifically indicated for treating cerebral edema in DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ethacrynic acid:</strong> Another loop diuretic, similar to bumetanide, and not used for DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nesiritide:</strong> A recombinant form of B-type natriuretic peptide used in acute heart failure, not for treating DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment for Dialysis Disequilibrium Syndrome (DDS), which can occur during or after dialysis, involves reducing cerebral edema. The first-line treatment is mannitol, an osmotic diuretic.</span></p>",
    "correct_choice_id": 80988,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84341,
    "choices": [
      {
        "id": 335936,
        "text": "<p>Nodules in the subcutaneous tissue</p>"
      },
      {
        "id": 335937,
        "text": "<p>Keratoderma blennorrhagica</p>"
      },
      {
        "id": 335938,
        "text": "<p>Balanitis circinata</p>"
      },
      {
        "id": 335939,
        "text": "<p>Ulcerations in the oral cavity</p>"
      }
    ],
    "text": "<p>Which of the following is NOT a characteristic finding in Reiter's syndrome?&nbsp;(NEET PG 2015)</p>",
    "unique_key": "Q9787247",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013403,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Correct Answer: A. Nodules in the subcutaneous tissue</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Reiter's syndrome, now termed Reactive Arthritis (ReA), is one of the seronegative spondyloarthropathies characterized by a clinical triad of arthritis, conjunctivitis, and urethritis that typically follows gastrointestinal or genitourinary infections. ReA has specific skin manifestations including circinate balanitis (inflammation of the penis glans), keratoderma blennorrhagica (pustular skin lesions on palms/soles), and oral ulcerations. Subcutaneous nodules are not characteristic of ReA but are instead a classic finding in rheumatoid arthritis.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Keratoderma blennorrhagica:</strong> This is a characteristic skin manifestation of Reiter's syndrome, appearing as pustular skin lesions on palms and soles that can resemble psoriasis. This distinctive rash is a key diagnostic feature of ReA.</p><p>&nbsp;</p><p><strong>Option C. Balanitis circinate:</strong> This is a characteristic finding in Reiter's syndrome, presenting as inflammation of the glans penis with circular lesions. It's one of the specific mucocutaneous manifestations of ReA.</p><p>&nbsp;</p><p><strong>Option D. Ulcerations in the oral cavity:</strong> Oral ulcerations are indeed a characteristic finding in Reiter's syndrome. These painless ulcers are part of the mucocutaneous manifestations that can occur in patients with ReA.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rheumatoid nodules (subcutaneous nodules) are characteristic of rheumatoid arthritis but not Reiter's syndrome/Reactive Arthritis, which instead features distinctive skin and mucosal lesions including keratoderma blennorrhagica, circinate balanitis, and oral ulcerations.</span></p>",
    "correct_choice_id": 335936,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55359,
    "choices": [
      {
        "id": 220897,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Miliary TB</span></span></p>"
      },
      {
        "id": 220898,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lung Cancer</span></span></p>"
      },
      {
        "id": 220899,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aspergilloma</span></span></p>"
      },
      {
        "id": 220900,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">ARDS</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 25-year-old patient presented with low-grade fever and cough. Chest X-ray is shown. Which of the following is the likely diagnosis?<strong> </strong>(FMGE JULY 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-102659.png\" style=\"height:293px; width:300px\" /></span></span></p>",
    "unique_key": "Q5140622",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013417,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Miliary TB</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The patient in this case presents with a low-grade fever and cough. The chest X-ray reveals multiple small nodules distributed throughout the bilateral lung fields, which is characteristic of miliary tuberculosis (TB). Miliary TB is a form of tuberculosis that occurs when a large number of Mycobacterium tuberculosis bacteria spread through the bloodstream to multiple organs, including the lungs. This results in the appearance of numerous tiny nodules on the chest X-ray.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Lung Cancer:</strong> While metastatic lung cancer can sometimes present with a similar pattern of multiple nodules on a chest X-ray, the presence of low-grade fever and the specific distribution of nodules are more indicative of miliary TB, especially in regions with a high prevalence of tuberculosis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Aspergilloma:</strong> Aspergillomas are fungal balls that typically form in pre-existing lung cavities, often resulting from previous tuberculosis infections. The chest X-ray appearance of aspergillomas is quite different from the diffuse nodules seen in miliary TB.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. ARDS:</strong> Acute Respiratory Distress Syndrome (ARDS) presents with diffuse alveolar damage and is characterized by rapid onset of widespread inflammation in the lungs. The chest X-ray findings for ARDS usually show diffuse bilateral infiltrates rather than the small, discrete nodules seen in miliary TB.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Miliary tuberculosis should be suspected in patients with low-grade fever, cough, and a chest X-ray showing multiple small nodules throughout the lung fields, especially in regions with high tuberculosis prevalence.</span></span></p>",
    "correct_choice_id": 220897,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92152,
    "choices": [
      {
        "id": 366924,
        "text": "<p><span style=\"font-size:14.0pt;\">Initiate treatment only if BP exceeds 160/100 mmHg</span></p>"
      },
      {
        "id": 366925,
        "text": "<p><span style=\"font-size:14.0pt;\">Start Amlodipine 5 mg once daily and advise lifestyle modification</span></p>"
      },
      {
        "id": 366926,
        "text": "<p><span style=\"font-size:14.0pt;\">Refer to a higher center for further evaluation</span></p>"
      },
      {
        "id": 366927,
        "text": "<p><span style=\"font-size:14.0pt;\">Start the patient on IV anti-hypertensive drugs</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male presents to a PHC for a routine check-up. His blood pressure readings on two separate occasions are 148/90 mmHg and 152/96 mmHg. He is asymptomatic and has no known comorbidities. What is the most appropriate next step in management according to current hypertension guidelines? (INICET MAY 2025)</span></p>",
    "unique_key": "Q6948494",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013394,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Start Amlodipine 5 mg once daily and advise lifestyle modification</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to current hypertension guidelines (ESC 2024, ACC/AHA 2017), when office blood pressure measurements consistently show readings \u2265140/90 mmHg on two separate visits, the patient has Stage 2 hypertension and requires immediate pharmacological treatment along with lifestyle modifications. The patient's readings of 148/90 and 152/96 mmHg clearly exceed the 140/90 threshold and require prompt treatment. While ideally a fixed-dose combination (dual therapy) is preferred according to most current guidelines, among the given options, starting amlodipine (a calcium channel blocker) represents appropriate single-agent therapy for this blood pressure range. Treatment should not be delayed, and lifestyle modifications should accompany pharmacological therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Initiate treatment only if BP exceeds 160/100 mmHg:</strong> This is outdated. Current guidelines recommend treatment for BP \u2265140/90 mmHg, not waiting until 160/100 mmHg.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Refer to a higher center for further evaluation:</strong> This is unnecessary for straightforward essential hypertension. The diagnosis is clear with two elevated readings, and treatment can be initiated at the primary healthcare level.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Start the patient on IV anti-hypertensive drugs:</strong> IV antihypertensives are only indicated for hypertensive emergencies with target organ damage, not for asymptomatic hypertension in an outpatient setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Blood pressure \u2265140/90 mmHg on two separate occasions requires immediate pharmacological treatment along with lifestyle modifications according to current hypertension guidelines.</span></p>",
    "correct_choice_id": 366925,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92152/Ini_Cet_May_2025_Medicine_Q_-_13new.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [
      "ClinicalVignette",
      "CriteriaBased",
      "TreatmentBased"
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92152/Ini_Cet_May_2025_Medicine_Q_-_13new.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11974,
    "choices": [
      {
        "id": 47861,
        "text": "<p><span style=\"font-size:12.0pt;\">Peritoneal Biopsy</span></p>"
      },
      {
        "id": 47862,
        "text": "<p><span style=\"font-size:12.0pt;\">Start ATT</span></p>"
      },
      {
        "id": 47863,
        "text": "<p><span style=\"font-size:12.0pt;\">Observation</span></p>"
      },
      {
        "id": 47864,
        "text": "<p><span style=\"font-size:12.0pt;\">Laparotomy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with cough, cold, fever, and malaise associated with weight loss and ascites. The patient does not have any evidence of cirrhosis and her coagulation profile is normal. Ascitic fluid analysis showed elevated adenosine deaminase. What can be done next? (INICET NOV 2022)</span></p>",
    "unique_key": "Q5073104",
    "question_audio": null,
    "question_video": null,
    "map_id": 35013399,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Start ATT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In countries with a high prevalence of tuberculosis, such as India, the presence of elevated adenosine deaminase (ADA) in ascitic fluid is highly suggestive of abdominal tuberculosis (TB). ADA is a useful diagnostic marker for TB, particularly when its levels are significantly elevated (e.g., above 39 IU/L). Given the clinical context of weight loss, fever, and ascites, along with a high ADA level, it is reasonable to initiate anti-tubercular therapy (ATT) without further invasive testing. Starting ATT and monitoring the patient's response is an effective and practical approach, especially in resource-limited settings. This strategy avoids unnecessary invasive procedures like peritoneal biopsy, which should be reserved for cases where there is doubt about the diagnosis or if the patient does not respond to initial therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Peritoneal Biopsy:</strong> While peritoneal biopsy is the gold standard for diagnosing peritoneal TB, it is invasive and resource-intensive. In high-prevalence areas, where elevated ADA levels strongly suggest TB, initiating ATT is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Observation:</strong> Given the significant clinical symptoms and elevated ADA levels, mere observation is not appropriate. Delay in treatment could lead to worsening of the patient\u2019s condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Laparotomy:</strong> Laparotomy is an invasive surgical procedure and is not warranted for diagnosing TB when non-invasive methods like ADA testing and clinical presentation strongly suggest the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In high-prevalence countries for tuberculosis, elevated adenosine deaminase (ADA) in ascitic fluid, along with clinical signs, is sufficient to start anti-tubercular therapy (ATT) without the need for invasive procedures.</span></p>",
    "correct_choice_id": 47862,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq:Pyt (Medicine-6)';
        const quizFilename = 'late-night-pyq-pyt-medicine-6-0c6941a4.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>